Expert Review of Vaccines, Volume 14, Issue 1 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Vaccines, Volume 14, Issue 1 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Prospects for safe and effective vaccines against prion diseases
Neil Andrew Mabbott
Pages: 1-4
Published online: 30 Sep 2014
AbstractforProspects for safe and effective vaccines against prion diseases | Full Text | References | PDF (247.5 KB)
  • 2152 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?
Douglas G Widman & Ralph S Baric
Pages: 5-8
Published online: 24 Sep 2014
AbstractforDengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design? | Full Text | References | PDF (323 KB)
  • 1375 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Racotumomab–alum vaccine for the treatment of non-small-cell lung cancer
Ana María Hernández & Ana María Vázquez
Pages: 9-20
Published online: 25 Nov 2014
AbstractforRacotumomab–alum vaccine for the treatment of non-small-cell lung cancer | Full Text | References | PDF (595.7 KB)
  • 381 Views
  • 7 CrossRef citations
  • 0Altmetric

Review

Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases
Frances E Terry, Leonard Moise, Rebecca F Martin, Melissa Torres, Nils Pilotte, Steven A Williams & Anne S De Groot
Pages: 21-35
Published online: 05 Sep 2014
AbstractforTime for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases | Full Text | References | PDF (832.5 KB)
  • 3814 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation
Yuri M Vasiliev
Pages: 37-53
Published online: 27 Sep 2014
AbstractforChitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation | Full Text | References | PDF (433.6 KB)
  • 892 Views
  • 49 CrossRef citations
  • 0Altmetric
Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
Ioanna Christopoulou, Kenny Roose, Lorena Itatí Ibañez & Xavier Saelens
Pages: 55-67
Published online: 11 Sep 2014
AbstractforInfluenza vaccines to control influenza-associated bacterial infection: where do we stand? | Full Text | References | PDF (491.4 KB)
  • 466 Views
  • 18 CrossRef citations
  • 0Altmetric

Reviews

Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development
Alena Y Reguzova, Larisa I Karpenko, Ludmila V Mechetina & Igor M Belyakov
Pages: 69-84
Published online: 05 Nov 2014
AbstractforPeptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development | Full Text | References | PDF (686.7 KB)
  • 472 Views
  • 11 CrossRef citations
  • 0Altmetric

Review

Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic
Anita S Iyer, Jennifer A Ohtola & MA Julie Westerink
Pages: 85-97
Published online: 01 Oct 2014
AbstractforAge-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic | Full Text | References | PDF (406.7 KB)
  • 603 Views
  • 7 CrossRef citations
  • 0Altmetric
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
Eve Dubé, Maryline Vivion & Noni E MacDonald
Pages: 99-117
Published online: 06 Nov 2014
AbstractforVaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications | Full Text | References | PDF (666.5 KB)
  • 16240 Views
  • 533 CrossRef citations
  • 0Altmetric
Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs
Sandra D Isidean, Joseph E Tota, Julien A Gagnon & Eduardo L Franco
Pages: 119-133
Published online: 30 Sep 2014
AbstractforHuman papillomavirus vaccines: key factors in planning cost-effective vaccination programs | Full Text | References | PDF (379.4 KB)
  • 426 Views
  • 11 CrossRef citations
  • 0Altmetric
Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants
Ziyaad Dangor, Gaurav Kwatra, Alane Izu, Sanjay G Lala & Shabir A Madhi
Pages: 135-149
Published online: 22 Sep 2014
AbstractforReview on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants | Full Text | References | PDF (490.7 KB)
  • 619 Views
  • 31 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan
Masayoshi Shinjoh et al.
Article | Published online: 2 May 2024
Open Access
Accelerate vaccine development using seamless phase 2/3 trial designs
Jia-Ying Yang et al.
Article | Published online: 29 Apr 2024
Open Access
The zebrafish as a potential model for vaccine and adjuvant development
Peter J. Hotez et al.
Report | Published online: 25 Apr 2024
Open Access
Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies
Timo Ulrichs et al.
Comment | Published online: 24 Apr 2024
Open Access
View all latest articles